Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Cash from Operations: 2013-2018

Historic Cash from Operations for Armata Pharmaceuticals (ARMP) over the last 6 years, with Dec 2018 value amounting to -$3.2 million.

  • Armata Pharmaceuticals' Cash from Operations fell 34.87% to -$3.2 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$10.6 million, marking a year-over-year decrease of 15.61%. This contributed to the annual value of -$37.6 million for FY2024, which is 20.82% up from last year.
  • According to the latest figures from Q4 2018, Armata Pharmaceuticals' Cash from Operations is -$3.2 million, which was down 58.17% from -$2.0 million recorded in Q3 2018.
  • In the past 5 years, Armata Pharmaceuticals' Cash from Operations registered a high of -$593,000 during Q3 2017, and its lowest value of -$3.7 million during Q1 2014.
  • Over the past 3 years, Armata Pharmaceuticals' median Cash from Operations value was -$2.9 million (recorded in 2016), while the average stood at -$2.5 million.
  • In the last 5 years, Armata Pharmaceuticals' Cash from Operations soared by 81.06% in 2017 and then tumbled by 240.64% in 2018.
  • Over the past 5 years, Armata Pharmaceuticals' Cash from Operations (Quarterly) stood at -$3.2 million in 2014, then rose by 27.59% to -$2.3 million in 2015, then spiked by 35.35% to -$1.5 million in 2016, then plummeted by 58.14% to -$2.4 million in 2017, then plummeted by 34.87% to -$3.2 million in 2018.
  • Its Cash from Operations was -$3.2 million in Q4 2018, compared to -$2.0 million in Q3 2018 and -$1.9 million in Q2 2018.